Year |
Citation |
Score |
2005 |
Carrera MR, Trigo JM, Wirsching P, Roberts AJ, Janda KD. Evaluation of the anticocaine monoclonal antibody GNC92H2 as an immunotherapy for cocaine overdose. Pharmacology, Biochemistry, and Behavior. 81: 709-14. PMID 16005948 DOI: 10.1016/J.Pbb.2005.04.018 |
0.501 |
|
2004 |
Carrera MR, Meijler MM, Janda KD. Cocaine pharmacology and current pharmacotherapies for its abuse. Bioorganic & Medicinal Chemistry. 12: 5019-30. PMID 15351386 DOI: 10.1016/J.Bmc.2004.06.018 |
0.506 |
|
2004 |
Carrera MR, Kaufmann GF, Mee JM, Meijler MM, Koob GF, Janda KD. Treating cocaine addiction with viruses. Proceedings of the National Academy of Sciences of the United States of America. 101: 10416-21. PMID 15226496 DOI: 10.1073/Pnas.0403795101 |
0.501 |
|
2004 |
Carrera MR, Ashley JA, Hoffman TZ, Isomura S, Wirsching P, Koob GF, Janda KD. Investigations using immunization to attenuate the psychoactive effects of nicotine. Bioorganic & Medicinal Chemistry. 12: 563-70. PMID 14738965 DOI: 10.1016/J.Bmc.2003.11.029 |
0.347 |
|
2001 |
Carrera MR, Ashley JA, Wirsching P, Koob GF, Janda KD. A second-generation vaccine protects against the psychoactive effects of cocaine. Proceedings of the National Academy of Sciences of the United States of America. 98: 1988-92. PMID 11172063 DOI: 10.1073/Pnas.98.4.1988 |
0.513 |
|
2000 |
Carrera MR, Ashley JA, Zhou B, Wirsching P, Koob GF, Janda KD. Cocaine vaccines: antibody protection against relapse in a rat model. Proceedings of the National Academy of Sciences of the United States of America. 97: 6202-6. PMID 10823960 DOI: 10.1073/Pnas.97.11.6202 |
0.51 |
|
1995 |
Carrera MR, Ashley JA, Parsons LH, Wirsching P, Koob GF, Janda KD. Suppression of psychoactive effects of cocaine by active immunization. Nature. 378: 727-30. PMID 7501020 DOI: 10.1038/378727A0 |
0.512 |
|
Show low-probability matches. |